J. Kevin Judice
2021
In 2021, J. Kevin Judice earned a total compensation of $5.6M as Chief Executive Officer at DICE Therapeutics, a 774% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $300,000 |
|---|---|
| Option Awards | $3,187,129 |
| Salary | $465,039 |
| Stock Awards | $1,609,795 |
| Total | $5,561,963 |
Judice received $3.2M in option awards, accounting for 57% of the total pay in 2021.
Judice also received $300K in non-equity incentive plan, $465K in salary and $1.6M in stock awards.
Rankings
In 2021, J. Kevin Judice's compensation ranked 2,302nd out of 12,415 executives tracked by ExecPay. In other words, Judice earned more than 81.5% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 2,302 out of 12,415 | 82nd |
Division Manufacturing | 898 out of 5,508 | 84th |
Major group Chemicals And Allied Products | 344 out of 2,378 | 86th |
Industry group Drugs | 298 out of 2,099 | 86th |
Industry Pharmaceutical Preparations | 192 out of 1,549 | 88th |
Source: SEC filing on April 26, 2022.
Judice's colleagues
We found two more compensation records of executives who worked with J. Kevin Judice at DICE Therapeutics in 2021.